Drinkable gene therapy foam for the treatment of constrictive esophageal carcinoma. [PDF]
Stephan SB +3 more
europepmc +1 more source
Basal cell subsets, as biomarker to predict the therapeutic effect of neoadjuvant therapy for esophageal carcinoma. [PDF]
Xin X +8 more
europepmc +1 more source
Barriers to Guideline-Based Management of Esophageal Carcinoma: A Narrative Review With Special Reference to North East India. [PDF]
Kumar S +5 more
europepmc +1 more source
Stemness signature RBBP7 reprograms the immune microenvironment to inform a prognostic model in esophageal carcinoma. [PDF]
Liu Y, Yang X, Du R, Wu L, Wu Q.
europepmc +1 more source
Patterns of Lymph Node Metastases After Multimodality Therapy in Esophageal Carcinoma Treated with Robot-Assisted Minimally Invasive Esophagectomy (RAMIE). [PDF]
Sanders ME +8 more
europepmc +1 more source
CD172a<sup>+</sup> tumor-associated macrophages drive immunosuppression and predict poor prognosis in esophageal carcinoma. [PDF]
Zhang X, Gu X, Gao W, Shao W.
europepmc +1 more source
Enrichment of T: A→A: T substitutions in the TP53 gene in esophageal carcinoma with high Fusobacterium burden. [PDF]
Tahara T +10 more
europepmc +1 more source
An Immune-privileged niche mediates immunotherapy resistance in esophageal carcinoma. [PDF]
Wan L +11 more
europepmc +1 more source
[Expression of Concern] Radiosensitization of esophageal carcinoma cells by knockdown of RNF2 expression. [PDF]
Yang XX +6 more
europepmc +1 more source

